Lifepak Defibrillator recall: Device Dysfunction
Device Dysfunction
The hazard: Device safety concern
The manufacturer or the FDA identified a problem with this device. The model, lot and catalogue numbers are what define the scope.
What the notice says: The company is notifying certain LIFEPAK 15 customers of an issue that may cause the device to lock up after a defibrillation shock is delivered.
Why it matters: The FDA recorded an enforcement action against this device. Most device recalls are corrections rather than removals, so the device often stays in use while the manufacturer issues a fix.
Recall details
- Published
- February 1, 2019
- Risk level
- Elevated risk
- Issued by
- U.S. Food and Drug Administration
- Brand
- Lifepak
- Product type
- Medical devices
Products covered by this recall
Defibrillator
What the company announced
Stryker announced today that the company is launching a voluntary field action on specific units of the LIFEPAK 15 Monitor/Defibrillators.
The company is notifying certain LIFEPAK 15 customers of an issue that may cause the device to lock up after a defibrillation shock is delivered. The lock-up condition is defined as a blank monitor display with LED lights on, indicating power to the device, but no response in the keypad and device functions. A device in this condition has the potential to delay delivery of therapy, and this delay in therapy has the potential to result in serious injury or death.
The company is contacting customers with impacted devices to schedule the correction of their device(s), which will include an update to the firmware for a component on the System Printed Circuit Board Assembly. Stryker anticipates that all devices subject to this field action will be serviced by December 31, 2019. If a customer experiences this issue, they should contact Stryker as soon as possible at 1 800 442 1142 and selecting option 7.
Since the initial commercialization of LIFEPAK 15 in 2009, Stryker has become aware of 58 complaints reported globally for this issue, including 6 events in which the patient died following a delay in therapy. In all six of these cases, at least one shock was delivered prior to the device experiencing the lock-up condition. There are 13,003 devices potentially impacted by this issue and within scope of this field action.
The company is instructing customers to continue to use their LIFEPAK 15 Monitor/Defibrillator according to the Operating Instructions until the correction can be completed. Device Automatic Self-Tests do not identify this fault, as it occurs during defibrillation. Customers should continue to perform the daily check as described in the Operator’s Checklist, specifically, the QUIK-COMBO therapy cable check as described in the General Maintenance and Testing Section (pages 10-4 and the LIFEPAK 15 Monitor/Defibrillator Operator’s Checklist, number 7).
If a device exhibits the lockup condition during patient use, the steps from the General Troubleshooting Section (page 10-18) of the LIFEPAK 15 Monitor/Defibrillator Operating Instructions should be immediately followed:
Press and hold ON until the LED turns off (~5 seconds). Then press ON to turn the device back on.
If the device does not turn off, remove both batteries and disconnect the device from the power adapter, if applicable. Then reinsert batteries and/or, reconnect the power adapter, and press ON to turn the device back on.
Information about this notice is available at: http://www.strykeremergencycare.com/productnotices . Impacted customers will be notified by letter and will be requested to verify their device status. Customers with questions regarding this notification, please contact Stryker by calling 1 800 442 1142, option 7, 6:00 a.m. to 4:00 p.m. (Pacific) Monday – Friday, or by email to [email protected] or fax to 1 425 867 4948.
In addition to contacting Stryker, any potential quality problems or adverse reactions or events associated with the use of a product from Stryker may be reported to the U. S. Food and Drug Administration’s MedWatch Safety Information and Adverse Event Reporting Program online at https://www.fda.gov/safety/medwatch/ , by phone 1 800 332 1088 or fax 1 800 FDA 0178.
Reproduced from the company announcement posted on fda.gov. Links and contact forms in the original are not repeated here; the official notice below has them.
What to do about Device
Lifepak — The manufacturer or the FDA identified a problem with this device. The model, lot and catalogue numbers are what define the scope.
- Match the model, catalogue, lot and serial numbers on your device against the identifiers on this page.
- If you are a facility, quarantine affected stock and log the correction.
- Report device problems to the FDA through MedWatch.
- If the device is implanted or you depend on it daily, speak to your clinician before changing how you use it.
Who pays for a device recall
The manufacturer funds the remedy. The practical question is usually which link in the chain executes it.
- If a clinic fitted or supplied the device, start there — they hold the serial-number records the manufacturer needs.
- Ask for written confirmation that the remedy was applied to your serial number. That is what an insurer or a future clinician will want to see.
- If you bought it yourself online or from a pharmacy, go to the manufacturer’s recall page rather than the retailer; device claims are handled centrally.
- Where the remedy is a software update, there is nothing to claim, but do confirm the version changed afterwards.
Company contact: Striker — Consumers: Stryker, 1-800-442-1142, [email protected]
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Company recall announcements record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Lifepak medical devices recalled?
Device Dysfunction The company is notifying certain LIFEPAK 15 customers of an issue that may cause the device to lock up after a defibrillation shock is delivered.
How do I know if I have the recalled product?
The notice does not publish package codes for this recall. Compare the product name, size and the purchase window against the official FDA — Company recall announcements record, and contact the company if you are unsure.
What should I do with it right now?
Match the model, catalogue, lot and serial numbers on your device against the identifiers on this page.
Can I get my money back?
If a clinic fitted or supplied the device, start there — they hold the serial-number records the manufacturer needs.
Related recalls
-
Class II · 10 days ago
Howmedica Osteonics Corp. TS Universal Baseplate Finishing Tray, Triathlon recall: Reprocessing instructions provided in LSTPI-B specify a sterilization dry
Reprocessing instructions provided in LSTPI-B specify a sterilization dry time of 30 minutes for the trays sterilized in blue wrap. When blue wrap is…
-
Class II · 10 days ago
Ferno-Washington Inc Power F2 Powered Fastening System, Power F2 recall: Firmware issue may result in intermittent loss or degradation of powered
Firmware issue may result in intermittent loss or degradation of powered functionality when paired with compatible stretcher. The issue may lead to…
-
Class II · 10 days ago
Howmedica Osteonics Corp. Triathlon Hinge Femoral Prep Tray recall: Reprocessing instructions provided in LSTPI-B specify a sterilization dry
Reprocessing instructions provided in LSTPI-B specify a sterilization dry time of 30 minutes for the trays sterilized in blue wrap. When blue wrap is…
-
Class II · 10 days ago
Medline surgical convenience kits labeled as: 1) Open Heart Pack A & recall: Medical convenience kits were distributed containing cannula components
Medical convenience kits were distributed containing cannula components which do not conform to ISO 80369-7 dimensional requirements and may…
-
Class I · 10 days ago
Instrumentation Laboratory HemoslL AcuStar HIT-lgG recall: Potential for invalid calibration curve or negative mean bias of up to 47%
Potential for invalid calibration curve or negative mean bias of up to 47% with patient samples.
-
Class II · 10 days ago
Cook Incorporated Williams Cystoscopic Injection Needles recall: The female Luer lock adapter component in the affected device lots
The female Luer lock adapter component in the affected device lots may not have been correctly seated due to misalignment and inadequate torquing…